Target intelligence / Profile preview

MicroRNA 15b (miR-15b)

Target
miR-15b
Molecular classification
MicroRNA (miRNA), Non-coding RNA, Regulatory RNA
01

Overview

MicroRNA 15b (miR-15b) is a small non-coding RNA, approximately 22 nucleotides long, encoded by the MIR15B gene. It functions as a post-transcriptional regulator of gene expression by targeting mRNAs for degradation or translational repression, and is part of the miR-15/16 cluster. MiR-15b modulates crucial cellular processes such as cell cycle progression, apoptosis, DNA damage response, cell proliferation, and differentiation (notably in osteoblasts)[1][2][3][4]. It has complex roles in human disease, acting as either an oncogene or a tumor suppressor depending on cellular context. MiR-15b dysregulation is implicated in several cancers, cardiovascular diseases, neurodegenerative disorders, metabolic conditions, and response to radiation-induced tissue injury. Its functions are mediated through modulation of target genes involved in proliferation, survival, and DNA repair pathways, making it a potential biomarker and therapeutic target in various diseases[1][2][3][4].

Other names
hsa-miR-15bMIR15BMIRN15Bhsa-mir-15bmiR-15b-5p
02

Mechanism of action

Regulation of mRNA stability and translation via binding to 3' UTRs of target genes. Modulation of drug sensitivity/resistance (e.g., increasing 5-FU sensitivity in colorectal cancer). Influence on signal transduction pathways (e.g., ATM/Chk1/p53 for DNA damage response).

03

Biological functions

Post-transcriptional gene regulationCell cycle controlApoptosisDNA damage response and repairCell proliferation and growthDifferentiations (notably osteoblast differentiation)
04

Disease associations

Cancer (as both oncogene and tumor suppressor, context-dependent)Cardiovascular diseaseNeurodegenerative disease (Alzheimer’s disease)Metabolic disordersRadiation-associated lung disease
05

Safety considerations

Dual role in oncogenesis and tumor suppression may limit therapeutic strategiesOff-target effects due to multi-target gene regulationComplex context-dependent effects in different tissues and diseases
06

Interacting drugs

5-fluorouracil (5-FU)
07

Biomarkers

Expression level of miR-15b (as a potential biomarker for cancer prognosis and therapy response)miR-15b as a biomarker for sensitivity to anti-PD-1 therapy in colitis-associated cancer

Beyond the preview

Go deeper on MicroRNA 15b (miR-15b).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MicroRNA 15b (miR-15b).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call